Eli Lilly Income from Continuous Operations 2010-2024 | LLY

Eli Lilly income from continuous operations for the twelve months ending December 31, 2024 was $10.590B, a 102.08% increase year-over-year.

  • Eli Lilly annual income from continuous operations for 2024 was $10.59B, a 102.08% increase from 2023.
  • Eli Lilly annual income from continuous operations for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual income from continuous operations for 2022 was $6.245B, a 11.88% increase from 2021.

Eli Lilly Income from Continuous Operations 2010-2024 | LLY

  • Eli Lilly annual income from continuous operations for 2024 was $10.59B, a 102.08% increase from 2023.
  • Eli Lilly annual income from continuous operations for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual income from continuous operations for 2022 was $6.245B, a 11.88% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B